Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair

人间充质干细胞定向分化用于骨修复

基本信息

  • 批准号:
    7144909
  • 负责人:
  • 金额:
    $ 32.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-15 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this project is to create new bone graft materials based on the directed differentiation of adult human mesenchymal stem cells (hMSC) in defined three-dimensional (3D) microenvironments, which can be delivered as a paste directly to the site of bone repair. hMSC are a promising autogenous cell source for bone tissue engineering because of their demonstrated ability to proliferate, as well as to clearly differentiate into the osteogenic lineage. A main factor limiting their use in bone repair is the inability to reliably control the induction and maintenance of osteogenic differentiation. This project directly addresses this issue by carefully controlling the extracellular environment immediately surrounding hMSC, by embedding them in protein hydrogel beads (20-200 um in diameter) of defined extracellular matrix (ECM) and growth factor composition. The central hypothesis is that hMSC differentiation can be directed through structural and compositional changes in the cellular microenvironment. The combination of specific integrin binding to natural ECM proteins and highly efficient, local delivery of growth factors in a 3D microenvironment is expected to provide a potent stimulus for osteogenic differentiation of hMSC. The Specific Aims of this project are to: 1] identify 3D extracellular microenvironment formulations that consistently promote differentiation of hMSC towards the osteogenic phenotype, 2] augment the extracellular microenvironment with BMP-2, a growth factor known to have potent osteoinductive effects, 3] adapt the use of defined cellular microenvironments to high density culture, and test them as an injectable cell delivery system in vitro, and 4] test 3D matrix-embedded hMSC in vivo in a segmental defect model in immunodeficient rats. The approach of creating defined 3D bead microenvironments addresses four key elements that are critical to effective bone repair: i] the presence of living osteogenic cells (hMSC), ii] an osteoinductive scaffold (the natural ECM proteins collagen I and vitronectin), iii] osteoinductive growth factors to provide signals to the resident cells (BMP-2), and iv] an adequate blood supply to support cell growth and function (by providing void spaces between beads for vascular ingrowth and VEGF delivery in vivo). This project is aimed at clinical problems that can benefit from therapies that accelerate bone healing in a difficult environment, such as avascular necrosis, spinal fusion and implant fixation. It will yield fundamental knowledge of how hMSC phenotype can be controlled by the 3D extracellular environment, and will therefore have broad impact on regenerative medicine. In the field of orthopaedic tissue engineering, it will yield a new cell-based bone repair therapy.
描述(由申请人提供):该项目的长期目标是基于定义的三维(3D)微环境的成年人类间充质干细胞(HMSC)的定向分化,可以创建新的骨移植物材料,这些微环境可以直接作为糊剂传递到骨修复的部位。 HMSC是骨组织工程的有前途的自源细胞来源,因为它们具有增殖能力,并且可以清楚地分化为成骨谱系。限制其在骨修复中使用的主要因素是无法可靠地控制成骨分化的诱导和维持。该项目通过仔细控制HMSC周围周围的细胞外环境直接解决了这一问题,将它们嵌入定义的细胞外基质(ECM)和生长因子组成的蛋白质水凝胶珠(直径为20-200 um)中。中心假设是HMSC分化可以通过细胞微环境中的结构和组成变化引导。在3D微环境中,特定整合素与天然ECM蛋白的结合与高效的生长因子的局部递送的结合预计将为HMSC的成骨分化提供有效的刺激。 The Specific Aims of this project are to: 1] identify 3D extracellular microenvironment formulations that consistently promote differentiation of hMSC towards the osteogenic phenotype, 2] augment the extracellular microenvironment with BMP-2, a growth factor known to have potent osteoinductive effects, 3] adapt the use of defined cellular microenvironments to high density culture, and test them as an injectable cell体外递送系统和4]在免疫缺陷大鼠中的分段缺陷模型中测试3D矩阵嵌入的HMSC。 The approach of creating defined 3D bead microenvironments addresses four key elements that are critical to effective bone repair: i] the presence of living osteogenic cells (hMSC), ii] an osteoinductive scaffold (the natural ECM proteins collagen I and vitronectin), iii] osteoinductive growth factors to provide signals to the resident cells (BMP-2), and iv] an adequate blood supply支持细胞的生长和功能(通过在体内提供血管向内生长和VEGF递送的珠子之间的空间)。该项目针对的是在艰难环境中加速骨骼愈合的疗法,例如血管坏死,脊柱融合和植入物固定。它将产生有关如何通过3D细胞外环境控制HMSC表型的基本知识,因此将对再生医学产生广泛的影响。在骨科组织工程领域,它将产生新的基于细胞的骨修复疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAN P. STEGEMANN其他文献

JAN P. STEGEMANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAN P. STEGEMANN', 18)}}的其他基金

Clincial Immersion and Experiential Learning in Medical Product Innovation
医疗产品创新的临床沉浸和体验式学习
  • 批准号:
    8848576
  • 财政年份:
    2015
  • 资助金额:
    $ 32.21万
  • 项目类别:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
使用成骨和血管生成组织模块进行骨再生
  • 批准号:
    9295974
  • 财政年份:
    2014
  • 资助金额:
    $ 32.21万
  • 项目类别:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
使用成骨和血管生成组织模块进行骨再生
  • 批准号:
    9088366
  • 财政年份:
    2014
  • 资助金额:
    $ 32.21万
  • 项目类别:
Bone Regeneration Using Osteogenic and Vasculogenic Tissue Modules
使用成骨和血管生成组织模块进行骨再生
  • 批准号:
    8816857
  • 财政年份:
    2014
  • 资助金额:
    $ 32.21万
  • 项目类别:
Modular Assembly of Interdigitated Osteochondral Interfaces
叉指骨软骨接口的模块化组装
  • 批准号:
    8512268
  • 财政年份:
    2013
  • 资助金额:
    $ 32.21万
  • 项目类别:
Modular Assembly of Interdigitated Osteochondral Interfaces
叉指骨软骨接口的模块化组装
  • 批准号:
    8640078
  • 财政年份:
    2013
  • 资助金额:
    $ 32.21万
  • 项目类别:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
人间充质干细胞定向分化用于骨修复
  • 批准号:
    7477826
  • 财政年份:
    2006
  • 资助金额:
    $ 32.21万
  • 项目类别:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
人间充质干细胞定向分化用于骨修复
  • 批准号:
    7271371
  • 财政年份:
    2006
  • 资助金额:
    $ 32.21万
  • 项目类别:
Directed Differentiation of Human Mesenchymal Stem Cells for Bone Repair
人间充质干细胞定向分化用于骨修复
  • 批准号:
    7669341
  • 财政年份:
    2006
  • 资助金额:
    $ 32.21万
  • 项目类别:
Composite Scaffolds for Vascular Tissue Engineering
血管组织工程复合支架
  • 批准号:
    6915572
  • 财政年份:
    2004
  • 资助金额:
    $ 32.21万
  • 项目类别:

相似国自然基金

钛基骨植入物表面电沉积镁氢涂层及其促成骨性能研究
  • 批准号:
    52371195
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
TLR3介导巨噬细胞M2极化调控BMSCs成骨分化延缓骨质疏松症的作用机制及右归丸的干预研究
  • 批准号:
    82374486
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
新疆沙棘果基于自噬-铁死亡通路对低氧条件下牙周骨组织改建的作用及机制研究
  • 批准号:
    82360956
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
髋臼盂唇重建手术相关的移植物腱骨愈合及重塑的机制研究
  • 批准号:
    82372418
  • 批准年份:
    2023
  • 资助金额:
    74 万元
  • 项目类别:
    面上项目
高强韧生物玻璃/聚乙烯醇双网络水凝胶在大段骨缺损中的骨再生作用及机制研究
  • 批准号:
    32371510
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Specificity of RPSA-dependent translational control in mouse and human fetal spleen cells
小鼠和人胎儿脾细胞中 RPSA 依赖性翻译控制的特异性
  • 批准号:
    10647605
  • 财政年份:
    2023
  • 资助金额:
    $ 32.21万
  • 项目类别:
The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia
Rpl5 单倍体不足在 Diamond Blackfan 贫血造血干/祖细胞功能中的作用
  • 批准号:
    10368461
  • 财政年份:
    2022
  • 资助金额:
    $ 32.21万
  • 项目类别:
Assessment of reproductive outcomes on adult offspring from in vitro fertilization using a mouse model
使用小鼠模型评估体外受精成年后代的生殖结果
  • 批准号:
    10389163
  • 财政年份:
    2022
  • 资助金额:
    $ 32.21万
  • 项目类别:
Assessment of reproductive outcomes on adult offspring from in vitro fertilization using a mouse model
使用小鼠模型评估体外受精成年后代的生殖结果
  • 批准号:
    10652260
  • 财政年份:
    2022
  • 资助金额:
    $ 32.21万
  • 项目类别:
The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia
Rpl5 单倍体不足在 Diamond Blackfan 贫血造血干/祖细胞功能中的作用
  • 批准号:
    10578722
  • 财政年份:
    2022
  • 资助金额:
    $ 32.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了